- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02937428
To Look or Not to Look at the Needle During Vaccination
October 23, 2016 updated by: Anna Taddio, University of Toronto
To Look or Not to Look? Pilot Study of the Effectiveness of a Simple Psychological Intervention in Reducing Vaccination Pain and Fear in Adult
It is common for people to advise individuals undergoing vaccination to look away from the needle to make them hurt less and be less scary.
However, this advice is not backed up by research evidence.
the purpose of this study is to learn about how looking away vs. looking at the needle during vaccination makes people feel.
People will be randomized to 1 of 2 groups: look at the needle, look away.
Then they will undergo vaccination and report on pain and fear experienced.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
It is common for people to advise individuals undergoing vaccination to look away from the needle to make them hurt less and be less scary.
However, this advice is not backed up by experimental research evidence.
It is possible that looking away acts as a distraction and takes attention away from the needle, thus reducing pain.
However, it is also possible that looking at the needle is better because it prevents people's imaginations from making them think it is worse than it actually is.
To our knowledge, this is the first first randomized study to examine the effect of looking away vs. looking at the needle on pain and fear experienced during vaccinations.
Adult university students undergoing routine flu vaccination will be included.
Study Type
Interventional
Enrollment (Anticipated)
160
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5S 3M2
- Recruiting
- Anna Taddio
-
Principal Investigator:
- Pamela Simmons, RN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- undergraduate and graduate students at the University of Toronto's Leslie Dan Faculty of Pharmacy undergoing flu vaccination
Exclusion Criteria:
- less than 18 years of age or prior participation in the trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Look away and prefer to look
Participant who is self-identified as preferring to look at the needle is randomized to look away from the needle during vaccination
|
Participant looks away from the needle during vaccination
|
|
Active Comparator: Look at needle and prefer to look
Participant who is self-identified as preferring to look at the needle is randomized to look at the needle during vaccination
|
Participant looks at the needle during vaccination
|
|
Experimental: Look away and prefer to look away
Participant who is self-identified as preferring to look away from the needle is randomized to look away from the needle during vaccination
|
Participant looks away from the needle during vaccination
|
|
Active Comparator: Look at needle and prefer to look away
Participant who is self-identified as preferring to look away from the needle is randomized to look at the needle during vaccination
|
Participant looks at the needle during vaccination
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: immediately after vaccination (<5 minutes)
|
self-reported pain assessed after vaccination using a numerical rating scale (0-10)
|
immediately after vaccination (<5 minutes)
|
|
Fear
Time Frame: immediately after vaccination (<5 minutes)
|
self-reported fear assessed after vaccination using a numerical rating scale (0-10)
|
immediately after vaccination (<5 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment rate
Time Frame: before vaccination (1 day to 4 weeks)
|
percentage of people eligible that participate
|
before vaccination (1 day to 4 weeks)
|
|
Feasibility of recruitment of subjects in the 2 study strata (i.e., preference to look or not look)
Time Frame: immediately before vaccination (<5 minutes)
|
percentage of individuals that prefer to look or not look at baseline
|
immediately before vaccination (<5 minutes)
|
|
Duration of appointment
Time Frame: immediately after vaccination
|
Amount of time taken for appointment as per clock
|
immediately after vaccination
|
|
Attrition of participants
Time Frame: immediately after vaccination
|
number of participants that are lost/drop-out of study
|
immediately after vaccination
|
|
Preferences of participants
Time Frame: immediately after vaccination (<5 minutes)
|
participant preferences about interventions according to questionnaire
|
immediately after vaccination (<5 minutes)
|
|
Fidelity of intervention
Time Frame: During vaccination
|
Compliance with instruction to look at the needle or look away, according to checklist
|
During vaccination
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
March 1, 2017
Study Completion (Anticipated)
March 1, 2017
Study Registration Dates
First Submitted
October 13, 2016
First Submitted That Met QC Criteria
October 14, 2016
First Posted (Estimate)
October 18, 2016
Study Record Updates
Last Update Posted (Estimate)
October 25, 2016
Last Update Submitted That Met QC Criteria
October 23, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 33392
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination
-
University of TorontoWholehealth Pharmacy PartnersNot yet recruitingVaccination | Vaccination Reaction | Vaccination Pain | Vaccination PharmacyCanada
-
University of Massachusetts, WorcesterRecruiting
-
University of IowaNational Institute on Aging (NIA)CompletedVaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological AspectsUnited States
-
University of Roma La SapienzaCompletedVaccination Failure | Vaccination Adverse Events | Specific Antibody ResponseItaly
-
Xiamen UniversityXiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
University of PennsylvaniaCompletedVaccine Refusal | Vaccination Hesitancy | Human Papillomavirus VaccinationUnited States
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
Université de Reims Champagne-ArdenneRecruiting
-
University of EssexUniversity of Southern California; Kingston University; Department of Health...Completed
-
China National Biotec Group Company LimitedPeking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaboratorsCompleted
Clinical Trials on Look away from the needle
-
First Affiliated Hospital of Jinan UniversityUnknownGastroesophageal Reflux | Bariatric SurgeryChina
-
University of FloridaOcean Spray, Inc.Completed
-
Shanghai Proton and Heavy Ion CenterTerminatedHepatocellular CarcinomaChina
-
Biomedical Enterprises IncNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Unknown
-
Indonesia UniversityRecruiting
-
University of CyprusTel Aviv University; Youth Board of CyprusCompleted
-
University of PennsylvaniaSharpscueNot yet recruitingHemophilia A and BUnited States
-
Washington State UniversityUnknownSubstance Abuse | Risk Reduction | RIsky Sexual BehaviorUnited States
-
Universidad Miguel Hernandez de ElcheHospital Universitario San Juan de AlicanteUnknown
-
University of Texas Southwestern Medical CenterGilead SciencesTerminatedPulmonary Hypertension | Heart Failure With Preserved Ejection FractionUnited States